Brief: Treace Announces Interim Results From Align3d Clinical Study At ACFAS 2021

Treace Medical Concepts

19/05/2021 20:18

May 19 (Reuters) - Treace Medical Concepts Inc  TMCI.O :
    * TREACE ANNOUNCES INTERIM RESULTS FROM ALIGN3D™ CLINICAL
STUDY AT
ACFAS 2021
    * TREACE MEDICAL CONCEPTS INC - INTERIM ANALYSIS
DEMONSTRATED
EARLY RETURN TO WEIGHTBEARING IN A WALKING BOOT AT AN AVERAGE OF
8.3 DAYS
    * TREACE MEDICAL CONCEPTS INC - INTERIM ANALYSIS
DEMONSTRATED
SIGNIFICANT IMPROVEMENTS IN RADIOGRAPHIC MEASUREMENTS OF
3-DIMENSIONAL BUNION CORRECTION
    * TREACE MEDICAL CONCEPTS INC - INTERIM ANALYSIS
DEMONSTRATED 1.4%
RECURRENCE RATE OBSERVED (1 OUT OF 72 PATIENTS) AT 12 MONTHS
POST-SURGERY

Source text for Eikon:  ID:nGNX9Xnxpg 
Further company coverage:  TMCI.O 

 ((Reuters.Briefs@thomsonreuters.com;))